This site is intended for UK healthcare professionals only

Diabetes Professional Care
15-16 November 2023, Olympia London

The UK's leading event for the entire team involved in the prevention, treatment and management of diabetes and its related conditions.

Are you a UK healthcare professional?

We are unfortunately unable to allow patients to attend Diabetes Professional Care

If you would like more information on general practice or primary care, please refer to the NHS website.

Visit the NHS website

News

Subpage Hero

     

10 Nov 2022

TIME TO FEEL AT HOME WITH REAL-TIME CONTINUOUS GLUCOSE MONITORING (RT-CGM) – INTRODUCING DEXCOM ONE

TIME TO FEEL AT HOME WITH REAL-TIME CONTINUOUS GLUCOSE MONITORING (RT-CGM) – INTRODUCING DEXCOM ONE
A rt-CGM system, with no scanning and no finger pricks, will be available to people with diabetes on prescription, thanks to Dexcom.
Dexcom recently announced the availability of the easy-to-use Dexcom ONE real-time Continuous Glucose MonItoring (rt-CGM) System on prescription via the NHS England, Wales, Scotland and Northern Ireland drug tariff to everyone with type 1 or type 2 diabetes using insulin. This marks the first time a rt-CGM system, with no scanning and no finger pricks*, will be available to people with diabetes at the pharmacy level.

Karen Baxter, Vice President, UK & Ireland, Benelux, France and Spain at Dexcom: “The addition of Dexcom ONE to drug tariff is enormous progress towards improving choice of diabetes tech, providing an alternative to burdensome finger pricks* and scanning. We are incredibly proud of the diabetes community and are working hard to make it easier for them to access the best technology possible to manage their diabetes. As a next step, we will be working closely with healthcare professionals to ensure people can benefit as quickly as possible from wider availability of Dexcom CGM system.”

This is an incredible step forward following the new guidelines from the National Institute for Care and Excellence (NICE) which recommends adults with type 1 diabetes should be offered a choice of glucose sensor, children should be offered rt-CGM system and people with type 2 diabetes using insulin can be considered for rt-CGM system as an alternative to their current sensor.

National NHS Specialty Adviser for Diabetes, Professor Partha Kar: “The next step in the evolution of type 1 diabetes technology continues to unfold and at NHS England, we are thrilled to be part of the solution. With Dexcom ONE on prescription, more people will have access to potentially life-changing CGM technology, leading to better health outcomes and more choice for people with diabetes.”

Dexcom ONE is a smart and effective wearable sensor and transmitter that sends glucose data to a compatible smart device† via the Dexcom ONE mobile app† or receiver, the technology eliminates the need for painful finger pricks* and burdensome scanning while providing a complete picture of glucose levels and trends.

Dexcom rt-CGM system gives people with diabetes the power to take control of their glucose management and helps them feel more confident in making treatment decisions. Don’t miss us at Stand E40 and feel at home with CGM.

Learn more about Dexcom and rt-CGM at uk.provider.dexcom.com

*If your glucose alerts and readings from the Dexcom ONE do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. †For a list of compatible smart devices, please visit www.dexcom.com/compatibility

LBL-1001718 Rev001

View all News
Loading

Partners

Partner